Similarly, MFI of KLRG1 was increased on CD57+ NKhigh cells from KS/HIV at W0 compared to HIV+ asymptomatic men [CT, p = 0.0001; MT, p = 0.0411], and both treatment schemes increased the MFI of KLRG1 at W4 (CT, p = 0.0162 and MT, p = 0.0133) and W12 (CT, p = 0.0002 and MT, p = 0.0001) compared to W0 (Figure 7F). The gene discussed is KLRG1; the disease is Kaposi's sarcoma.